Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

API Manufacturing: SOP for Sample Tracking and Lab Numbering System – V 2.0

Posted on By

API Manufacturing: SOP for Sample Tracking and Lab Numbering System – V 2.0

Standard Operating Procedure for Sample Tracking and Lab Numbering System in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/152/2025
Supersedes SOP/API/152/2022
Page No. Page 1 of 10
Issue Date 14/04/2025
Effective Date 16/04/2025
Review Date 14/04/2026

1. Purpose

The purpose of this SOP is to establish a consistent and traceable system for assigning laboratory numbers to samples and to define a structured process for tracking the movement and status of samples received in the Quality Control (QC) department of the API manufacturing facility.

2. Scope

This SOP applies to all samples

received in the QC laboratory, including but not limited to raw materials, intermediates, in-process samples, finished APIs, packaging materials, cleaning samples, and stability samples.

3. Responsibilities

  • QC Analyst: Responsible for entering sample details, updating status, and ensuring traceability throughout the testing cycle.
  • QC Coordinator: Assign laboratory numbers and maintain the sample receipt and tracking log.
  • QC Head: Ensure implementation and periodic review of the sample numbering and tracking system.
See also  API Manufacturing: SOP for Trending of Analytical Results - V 2.0

4. Accountability

The Quality Control Head is accountable for ensuring that all samples are tracked and identified in compliance with regulatory and internal documentation standards.

5. Procedure

5.1 Sample Receipt

  1. All samples must be submitted with a duly filled Sample Intimation Form (SIF) or online request through the LIMS.
  2. QC Coordinator checks the following upon receipt:
    • Sample condition and integrity
    • Proper labeling and packaging
    • Sample type and associated batch information
  3. Samples that fail preliminary checks must be recorded and returned to the originator with justification.

5.2 Laboratory Number Assignment

  1. A unique laboratory number shall be assigned sequentially using the format: QC/YY/XXXX where:
    • QC = Quality Control
    • YY = Last two digits of the calendar year
    • XXXX = Serial number starting from 0001 every year
  2. Different types of samples may include additional suffixes:
    • RM: Raw Material (e.g., QC/25/0042-RM)
    • API: Finished API sample (e.g., QC/25/0045-API)
    • IPC: In-Process Control (e.g., QC/25/0051-IPC)
  3. All laboratory numbers must be recorded in the Laboratory Sample Receipt Logbook (Annexure-1).

5.3 Sample Labeling

  1. Each received sample shall be labeled with:
    • Lab number
    • Sample name and code
    • Batch number
    • Date of receipt
    • Storage condition (if applicable)
  2. Ensure that labels are clear, permanent, and affixed securely on each sample container.
See also  API Manufacturing: SOP for Reanalysis Protocol for Failed Samples - V 2.0

5.4 Sample Distribution and Tracking

  1. QC Coordinator distributes the sample to the concerned analyst along with the SIF and lab number details.
  2. Analyst updates the Sample Tracking Sheet (Annexure-2) with:
    • Date of testing initiation
    • Testing completion date
    • Analyst initials
    • Instrument ID used
  3. Any delays or hold status must be documented with reason and approved by the QC Head.

5.5 Result Entry and Review

  1. On completion of testing, analysts shall enter results in the analytical worksheet or LIMS, linking them with the assigned lab number.
  2. The reviewer shall cross-check test results, raw data, and lab number entries for consistency.
  3. Any discrepancy in sample identification or test results shall be investigated and logged.

5.6 Sample Retention and Disposal

  1. Retain a portion of the sample as per SOP for control and retesting purposes.
  2. Label control samples with a reference tag including the lab number.
  3. Dispose of excess or expired samples as per the Sample Disposal SOP.

5.7 Audits and Traceability

  1. QA may periodically review sample tracking logs for traceability and compliance.
  2. All lab numbers must be traceable back to:
    • Sample origin
    • Batch records
    • Test results and CoA
See also  API Manufacturing: SOP for Stability Testing of API Batches - V 2.0

6. Abbreviations

  • QC: Quality Control
  • API: Active Pharmaceutical Ingredient
  • IPC: In-Process Control
  • SIF: Sample Intimation Form
  • LIMS: Laboratory Information Management System

7. Documents

  1. Laboratory Sample Receipt Logbook (Annexure-1)
  2. Sample Tracking Sheet (Annexure-2)
  3. Sample Intimation Form

8. References

  • 21 CFR Part 211 – Subpart I: Laboratory Controls
  • ICH Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • WHO TRS No. 1019 – Annex 4

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Laboratory Sample Receipt Logbook

Date Lab No. Sample Type Batch No. Received From QC Coordinator
14/04/2025 QC/25/0123-API API BATCH1234 Production Sunita Reddy

Annexure-2: Sample Tracking Sheet

Lab No. Analyst Date of Issue Date of Completion Instrument ID Remarks
QC/25/0123-API Rajesh Kumar 14/04/2025 15/04/2025 HPLC-03 NA

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial SOP release New system implementation QA Head
14/04/2025 2.0 Included LIMS workflow and suffix coding Standardization QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Elixir Department: SOP for Minimizing Foaming During Mixing – V 2.0
Next Post: Biosimilars: SOP for Harvest Decision and Timing in Bioreactor Operations – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version